Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	29.43	88.08	68.05
Graham Fair Price	-65.61	6.67	19.38
PEG	224.72	2.93	-0.90
Price/Book	22.18	30.21	24.73
Price/Cash Flow	-38.01	330.52	533.19
Prices/Earnings	568.27	-335.64	50.23
Price/Sales	9.10	20.51	18.80
Price/FCF	-38.01	330.52	533.19
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-8.54	0.57	0.62
Operating Margin	-18.04	0.13	0.16
ROA	-84.61	< 0.005	< 0.005
ROE	0.12	-0.02	-81.72
ROIC	0.02	0.02	40.09
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.07	-86.61
Dividends QOQ	0.00	0.06	100.00
EBIT QOQ	-0.37	-0.26	29.82
EPS QOQ	-0.56	-1.15	-105.80
FCF QOQ	-0.88	0.59	-33.53
Revenue QOQ	0.19	-0.10	-47.89
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	275.26	245.36	-10.86
Days Sales Outstanding (DSO)	87.21	82.46	-5.45
Inventory Turnover	0.33	0.37	12.19
Debt/Capitalization	0.91	0.93	1.67
Quick Ratio	1.62	0.84	-48.45
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	11.65	9.37	-19.57
Cash	40.91	18.11	-55.73
Capex	-0.47	-0.43	7.80
Free Cash Flow	0.54	0.86	58.53
Revenue	15.32	13.80	-9.93
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.65	1.42	-13.79
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	17.58	23.22	32.09
Naive Interpretation	Member

06 - Financial Health · Weak

Rating